Chris Adams

Andarix

BIOGRAPHY

Chris Adams is the Founder and the CEO of Anzor Pharmaceuticals, leading work on FGF-based therapies for metabolic disorders and oncology. He is a serial life sciences entrepreneur in Massachusetts and has established several companies focused on developing breakthrough therapeutics and medical devices. His patents support treatments used by millions of patients worldwide, reflecting broad experience in drug development and commercial strategy.

Chris now advances innovative biotech solutions by guiding teams from early scientific concepts to practical therapies, helping accelerate development pathways and improve patient outcomes worldwide.